article

1. Use of Biologic or Targeted Synthetic Disease-Modifying Antirheumatic Drugs and Cancer Risk..  JAMA network open.  7:-. 2024
2. Escalation to Biologics After Methotrexate Among US Veterans with Rheumatoid Arthritis Grouped by Rural Versus Urban Areas..  Arthritis care & research.  2024
3. Frailty and its association with readmissions in patients with rheumatoid arthritis: A national readmissions database study..  Clinical rheumatology.  2024
4. Inflammation and aging-related disease: A transdisciplinary inflammaging framework..  GeroScience.  2024
5. Low Socioeconomic Status and Female Sex are Associated With Worse Functional Status in Axial Spondyloarthritis..  Arthritis care & research.  2024
6. Long-Term Mortality Following SARS-CoV-2 Infection in Rural Versus Urban Dwellers With Autoimmune or Inflammatory Rheumatic Disease: A Retrospective Cohort Analysis From the National COVID Cohort Collaborative..  Arthritis care & research.  2024
7. Association Between Frailty Status and Readmissions in Hospitalized Patients With Systemic Lupus Erythematosus..  ACR open rheumatology.  6:700-706. 2024
8. The Risk of Lung Cancer in Rheumatoid Arthritis and Rheumatoid Arthritis-Associated Interstitial Lung Disease..  Arthritis & rheumatology (Hoboken, N.J.).  2024
9. 2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Screening and Monitoring of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases..  Arthritis & rheumatology (Hoboken, N.J.).  76:1201-1213. 2024
10. 2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Screening and Monitoring of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases..  Arthritis care & research.  76:1070-1082. 2024
11. 2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Treatment of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases..  Arthritis care & research.  76:1051-1069. 2024
12. 2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Treatment of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases..  Arthritis & rheumatology (Hoboken, N.J.).  76:1182-1200. 2024
13. Effect of telephone reminders on adherence to anti-rabies vaccine amongst animal bite patients in North India: A randomised, single-blind, parallel-group, single-centre, interventional superiority trial..  IJID regions.  -. 2024
14. Prevalence and Factors Associated with De-escalation of Anti-TNFs in Older Adults with Rheumatoid Arthritis: A Medicare Claims-Based Observational Study..  Drugs & aging.  41:601-613. 2024
15. The Need for Classification Criteria of Immune Checkpoint Inhibitor-induced inflammatory Arthritis: A Scoping Review..  Rheumatic diseases clinics of North America.  50:325-335. 2024
16. Immune Checkpoint Inhibitor-induced Inflammatory Arthritis: Current Approaches to Management..  Rheumatic diseases clinics of North America.  50:269-279. 2024
17. Frailty and Risk of Serious Infections in Patients With Rheumatoid Arthritis Treated With Biologic or Targeted-Synthetic Disease-Modifying Antirheumatic Drugs..  Arthritis care & research.  76:627-635. 2024
18. Prognosis of Merkel cell carcinoma patients with autoimmune disorders, other types of immune dysfunction, or immunocompetent status: Analysis of 762 patients..  Journal of the American Academy of Dermatology.  90:1018-1020. 2024
19. Long-term safety of biologic and targeted synthetic disease modifying drugs in rheumatology..  Current opinion in rheumatology.  36:113-119. 2023
20. Initiation of Disease-Modifying Antirheumatic Drugs in Older Medicare Beneficiaries With New Diagnosis of Late-Onset Rheumatoid Arthritis..  ACR open rheumatology.  5:694-700. 2023
21. JAK inhibitors and black box warnings: what is the future for JAK inhibitors?.  Expert review of clinical immunology.  19:1-13. 2023
22. Hydroxychloroquine use is associated with reduced mortality risk in older adults with rheumatoid arthritis..  Clinical rheumatology.  43:87-94. 2023
23. Immune-related adverse events after immune check point inhibitors: Understanding the intersection with autoimmunity..  Immunological reviews.  318:81-88. 2023
24. Managing Cardiovascular and Cancer Risk Associated with JAK Inhibitors..  Drug safety.  46:1049-1071. 2023
25. Selective immune suppression using interleukin-6 receptor inhibitors for management of immune-related adverse events..  Journal for immunotherapy of cancer.  11. 2023
26. Awareness and Hesitancy of COVID-19 and other Vaccines among People Living with HIV/AIDS Attending Antiretroviral Therapy (ART) Center in North India..  Indian journal of community medicine : official publication of Indian Association of Preventive & Social Medicine.  48:492-496. 2023
27. 2022 American College of Rheumatology Guideline for Exercise, Rehabilitation, Diet, and Additional Integrative Interventions for Rheumatoid Arthritis..  Arthritis & rheumatology (Hoboken, N.J.).  75:1299-1311. 2023
28. 2022 American College of Rheumatology Guideline for Exercise, Rehabilitation, Diet, and Additional Integrative Interventions for Rheumatoid Arthritis..  Arthritis care & research.  75:1603-1615. 2023
29. Use of Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis: Supporting Shared Decision-Making Between Patients With Cancer and Clinicians..  ACR open rheumatology.  5:305-307. 2023
30. Racial/ethnic disparities in the risk of preterm birth among women with systemic lupus erythematosus or rheumatoid arthritis..  Clinical rheumatology.  42:2437-2444. 2023
31. Racial disparities in pregnancy outcomes among women with rheumatic diseases: A systematic literature review..  Seminars in arthritis and rheumatism.  -. 2023
32. Birth Outcomes and Rehospitalizations Among Pregnant Women With Rheumatoid Arthritis and Systemic Lupus Erythematosus and Their Offspring..  Arthritis care & research.  75:2022-2031. 2023
33. Burden, Causes and Outcomes of Hospitalization in Patients with Giant Cell Arteritis: A US National Cohort Study..  Arthritis care & research.  75:1830-1837. 2023
34. 2022 American College of Rheumatology Guideline for Vaccinations in Patients With Rheumatic and Musculoskeletal Diseases..  Arthritis & rheumatology (Hoboken, N.J.).  75:333-348. 2023
35. 2022 American College of Rheumatology Guideline for Vaccinations in Patients With Rheumatic and Musculoskeletal Diseases..  Arthritis care & research.  75:449-464. 2023
36. Supporting International Medical Graduates in Rheumatology: A Call to Action..  Arthritis & rheumatology (Hoboken, N.J.).  75:145-148. 2022
37. Predictors of Thirty-Day Hospital Readmissions in Systemic Lupus Erythematosus in the US: A Nationwide Study..  Arthritis care & research.  75:989-997. 2022
38. Rituximab is associated with worse COVID-19 outcomes in patients with rheumatoid arthritis: A retrospective, nationally sampled cohort study from the U.S. National COVID Cohort Collaborative (N3C)..  Seminars in arthritis and rheumatism.  -. 2022
39. The Impact of Disease Severity Measures on Survival in U.S. Veterans with Rheumatoid Arthritis-Associated Interstitial Lung Disease..  Rheumatology (Oxford, England).  61:4667-4677. 2022
40. Risk of Prostate Cancer in U.S. Veterans with Rheumatoid Arthritis..  Arthritis care & research.  75:785-792. 2022
41. Abnormal echocardiographic findings after COVID-19 infection: a multicenter registry..  The international journal of cardiovascular imaging.  39:1-2. 2022
42. Optimizing Medication Use in Older Adults With Rheumatic Musculoskeletal Diseases: Deprescribing as an Approach When Less May Be More..  ACR open rheumatology.  4:1031-1041. 2022
43. Genetic, social, and environmental risk factors in rheumatoid arthritis-associated interstitial lung disease..  Seminars in arthritis and rheumatism.  -. 2022
44. Prolonged COVID-19 symptom duration in people with systemic autoimmune rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey..  RMD open.  8. 2022
45. Determinants of Cervical Cancer Screening Patterns Among Women With Systemic Lupus Erythematosus..  The Journal of rheumatology.  49:1236-1241. 2022
46. The role of a noninvasive index 'Spo2/ Fio2' in predicting mortality among patients with COVID-19 pneumonia..  The American journal of emergency medicine.  -. 2022
47. Physical Function and Fatigue Recovery at 6-Months after Hospitalization for COVID-19..  PM & R : the journal of injury, function, and rehabilitation.  15:314-324. 2022
48. Associations between shortened telomeres and rheumatoid arthritis-associated interstitial lung disease among U.S. Veterans..  Respiratory medicine.  -. 2022
49. Association of rheumatoid arthritis with mortality in chronic kidney disease: a cohort study..  Clinical rheumatology.  41:2669-2676. 2022
50. Experience with telemedicine among rheumatology clinicians during the COVID-19 pandemic: an international survey..  Rheumatology advances in practice.  6:-. 2022
51. Effectiveness of COVID-19 vaccination in immune-mediated inflammatory diseases..  The Lancet. Rheumatology.  4:e380-e382. 2022
52. SARS-CoV-2 Infection and COVID-19 Outcomes in Rheumatic Diseases: A Systematic Literature Review and Meta-Analysis..  Arthritis & rheumatology (Hoboken, N.J.).  74:766-775. 2022
53. COVID-19 vaccine perceptions and uptake: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey..  The Lancet. Rheumatology.  4:e237-e240. 2022
54. Association Between Immune Dysfunction and COVID-19 Breakthrough Infection After SARS-CoV-2 Vaccination in the US..  JAMA internal medicine.  182:153-162. 2022
55. Non-English Language Preference Associated With Decreased Rheumatology Telehealth Use During the COVID-19 Pandemic..  ACR open rheumatology.  4:385-394. 2022
56. Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey..  RMD open.  7. 2021
57. 2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis..  Arthritis & rheumatology (Hoboken, N.J.).  73:1108-1123. 2021
58. 2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis..  Arthritis care & research.  73:924-939. 2021
59. Safety of immune checkpoint inhibitors in patients with cancer and pre-existing autoimmune disease..  Annals of translational medicine.  9:-. 2021
60. Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry..  Annals of the rheumatic diseases.  80:1137-1146. 2021
61. Impact of rheumatoid arthritis and biologic and targeted synthetic disease modifying antirheumatic agents on cancer risk and recurrence..  Current opinion in rheumatology.  33:292-299. 2021
62. Association of blood biomarkers and autoimmunity with immune related adverse events in patients with cancer treated with immune checkpoint inhibitors..  Scientific reports.  11:-. 2021
63. Clinical and laboratory features of patients with focal lymphocytic sialadenitis on minor salivary gland biopsy for sicca symptoms: A single-center experience..  Medicine.  100:-. 2021
64. Autoantibody Seropositivity and Risk for Interstitial Lung Disease in a Prospective Male-Predominant Rheumatoid Arthritis Cohort of U.S. Veterans..  Annals of the American Thoracic Society.  18:598-605. 2021
65. Musculoskeletal sarcoidosis: A single center experience over 15 years..  International journal of rheumatic diseases.  24:533-541. 2021
66. Association of Agricultural, Occupational, and Military Inhalants With Autoantibodies and Disease Features in US Veterans With Rheumatoid Arthritis..  Arthritis & rheumatology (Hoboken, N.J.).  73:392-400. 2021
67. Trends in Hospitalization Rates, Major Causes of Hospitalization, and In-Hospital Mortality in Rheumatoid Arthritis in the United States From 2000 to 2014..  ACR open rheumatology.  2:715-724. 2020
68. Pregnancy after bariatric surgery in women with rheumatic diseases and association with adverse birth outcomes..  Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.  17:406-413. 2020
69. Prevalence and the impact of hypogammaglobulinemia in newly diagnosed chronic lymphocytic lymphoma patients..  EJHaem.  1:537-544. 2020
70. Acute respiratory viral adverse events during use of antirheumatic disease therapies: A scoping review..  Seminars in arthritis and rheumatism.  50:1191-1201. 2020
71. Trends of lymphoma incidence in US veterans with rheumatoid arthritis, 2002-2017..  RMD open.  6. 2020
72. Coexistent Hyperuricemia and Gout in Rheumatoid Arthritis: Associations With Comorbidities, Disease Activity, and Mortality..  Arthritis care & research.  72:950-958. 2020
73. Association of body mass index on disease activity in axial spondyloarthritis: systematic review and meta-analysis..  RMD open.  6. 2020
74. Immunologic adverse events from immune checkpoint therapy..  Best practice & research. Clinical rheumatology.  34:-. 2020
75. Comparative Risk of Cardiovascular Events With Biologic and Synthetic Disease-Modifying Antirheumatic Drugs in Patients With Rheumatoid Arthritis: A Systematic Review and Meta-Analysis..  Arthritis care & research.  72:561-576. 2020
76. Immune-related adverse events in cancer patients treated with immune checkpoint inhibitors: A single-center experience..  Medicine.  2019
77. Impact of autoimmune rheumatic diseases on birth outcomes: A population-based study.  RMD Open.  2019
78. Impact of the pattern of interstitial lung disease on mortality in rheumatoid arthritis: A systematic literature review and meta-analysis.  Seminars in Arthritis and Rheumatism.  2019
79. Is Transdermal Multivitamin Patch Effective in Gastric Bypass Patients?.  Obesity Surgery.  2019
80. Malondialdehyde–Acetaldehyde Adducts and Antibody Responses in Rheumatoid Arthritis–Associated Interstitial Lung Disease.  Arthritis and Rheumatology.  2019
81. Rheumatoid arthritis: Therapeutic strategies after inadequate response to initial TNF inhibitor therapy.  Journal of Clinical Outcomes Management.  2019
82. Multicentric Reticulohistiocytosis: A Multicenter Case Series and Review of Literature.  Journal of Clinical Rheumatology.  2018
83. Large-scale deployment of a rice 6 K SNP array for genetics and breeding applications..  Rice (New York, N.Y.).  10:-. 2017
84. Abnormal thymic maturation and lymphoproliferation in MRL-Fas ^lpr/lpr mice can be partially reversed by synthetic oligonucleotides: Implications for systemic lupus erythematosus and autoimmune lymphoproliferative syndrome.  Lupus.  2017
85. Monoarticular Arthritis.  Medical Clinics of North America.  2017
86. Septic Arthritis and Prosthetic Joint Infections in Older Adults.  Infectious Disease Clinics of North America.  2017
87. Associations of Circulating Cytokines and Chemokines With Cancer Mortality in Men With Rheumatoid Arthritis..  Arthritis & rheumatology (Hoboken, N.J.).  68:2394-402. 2016
88. Alterations in nuclear structure promote lupus autoimmunity in a mouse model.  DMM Disease Models and Mechanisms.  2016
89. Interfering with baffled B cells at the lupus tollway: Promises, successes, and failed expectations.  Journal of Allergy and Clinical Immunology.  2016
90. Cat-scratch fever and lymphadenopathy in a rheumatoid arthritis patient on tocilizumab.  Journal of Clinical Rheumatology.  2015
91. Renal cell carcinoma metastatic to the orbit in a patient with wegener granulomatosis.  Journal of Neuro-Ophthalmology.  2015
92. Genomic alterations in abnormal neutrophils isolated from adult patients with systemic lupus erythematosus.  Arthritis Research and Therapy.  2014
93. Role of robotic-assisted surgery in benign esophageal diseases.  Journal of Robotic Surgery.  2014
94. Lower extremity mass.  Clinical Case Reports.  2013
95. Tuberous sclerosis and fulminant lupus in a young woman.  Journal of Clinical Rheumatology.  2013
96. What is the diagnosis for this rash?.  Clinical Case Reports.  2013
97. The T cell in Sjogren's syndrome: Force majeure, not spectateur.  Journal of Autoimmunity.  2012